Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
Rocket Pharmaceuticals Inc (NASDAQ: RCKT) closed the day trading at $4.24 down -0.70% from the previous closing price of $4.27. In other words, the price has decreased by -$0.70 from its previous closing price. On the day, 7.29 million shares were traded. RCKT stock price reached its highest trading level at $4.5093 during the session, while it also had its lowest trading level at $4.05.
Ratios:
For a better understanding of RCKT, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.39 and its Current Ratio is at 6.39. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
On July 25, 2025, BofA Securities Downgraded its rating to Neutral which previously was Buy but kept the price unchanged to $4.
Evercore ISI Downgraded its Outperform to In-line on May 30, 2025, while the target price for the stock was maintained at $5.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 14 ’25 when Militello John bought 28,918 shares for $3.96 per share.
Bjork Elisabeth bought 10,000 shares of RCKT for $34,100 on Aug 27 ’25. The Director now owns 40,000 shares after completing the transaction at $3.41 per share. On Aug 18 ’25, another insider, Militello John, who serves as the insider of the company, sold 699 shares for $3.06 each. As a result, the insider received 2,142 and left with 56,285 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RCKT now has a Market Capitalization of 457512384 and an Enterprise Value of 211220416.
Stock Price History:
The Beta on a monthly basis for RCKT is 0.63, which has changed by -0.7683125 over the last 52 weeks, in comparison to a change of 0.14201736 over the same period for the S&P500. Over the past 52 weeks, RCKT has reached a high of $18.89, while it has fallen to a 52-week low of $2.19. The 50-Day Moving Average of the stock is 29.51%, while the 200-Day Moving Average is calculated to be -28.32%.
Shares Statistics:
Over the past 3-months, RCKT traded about 3.83M shares per day on average, while over the past 10 days, RCKT traded about 3641900 shares per day. A total of 107.88M shares are outstanding, with a floating share count of 98.63M. Insiders hold about 8.60% of the company’s shares, while institutions hold 85.82% stake in the company. Shares short for RCKT as of 1759190400 were 13700652 with a Short Ratio of 3.58, compared to 1756425600 on 15488041. Therefore, it implies a Short% of Shares Outstanding of 13700652 and a Short% of Float of 24.72.
Earnings Estimates
At present, 14.0 analysts are actively evaluating the performance of Rocket Pharmaceuticals Inc (RCKT) in the stock market.The consensus estimate for the next quarter is -$0.46, with high estimates of -$0.33 and low estimates of -$0.61.
Analysts are recommending an EPS of between -$1.69 and -$2.36 for the fiscal current year, implying an average EPS of -$2.13. EPS for the following year is -$1.11, with 12.0 analysts recommending between $0.69 and -$1.96.
